Clinical Trial Update: PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy [EARLY_Phase 1]

View source ↗

Summary

This Clinical Trial Update reports on an early-phase 1 study using PET quantitative assessments to measure solid tumor response to immune checkpoint blockade in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Melanoma, Renal Cell Carcinoma (RCC) | EARLY_Phase 1 | Status: COMPLETED